ReWalk Robotics - RWLK Stock Forecast, Price & News

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Analyst Ratings Changes

Several equities analysts have recently weighed in on RWLK shares. StockNews.com started coverage on shares of ReWalk Robotics in a research note on Sunday. They issued a "sell" rating on the stock. HC Wainwright decreased their price target on shares of ReWalk Robotics from $3.50 to $2.50 and set a "buy" rating on the stock in a research note on Wednesday, August 10th.

ReWalk Robotics Price Performance

RWLK Stock traded up $0.02 during trading on Monday, reaching $1.09. 2,970 shares of the stock were exchanged, compared to its average volume of 369,990. The business has a 50 day moving average price of $0.99 and a 200-day moving average price of $1.04. ReWalk Robotics has a 1 year low of $0.81 and a 1 year high of $2.78.

ReWalk Robotics (NASDAQ:RWLK - Get Rating) last announced its quarterly earnings results on Friday, May 13th. The medical device company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.02). The company had revenue of $0.88 million for the quarter, compared to analyst estimates of $2.20 million. ReWalk Robotics had a negative net margin of 270.83% and a negative return on equity of 17.60%. During the same quarter in the prior year, the business earned ($0.08) earnings per share. Analysts predict that ReWalk Robotics will post -0.27 earnings per share for the current year.

Insider Activity at ReWalk Robotics

In other ReWalk Robotics news, major shareholder Global Fund Lp Lind II acquired 26,702 shares of the company's stock in a transaction that occurred on Friday, July 15th. The stock was purchased at an average price of $1.02 per share, for a total transaction of $27,236.04. Following the completion of the acquisition, the insider now owns 4,380,430 shares of the company's stock, valued at approximately $4,468,038.60. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders acquired 284,794 shares of company stock worth $285,080. Corporate insiders own 0.78% of the company's stock.